Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.
Brain activation changes during locomotion in middle-aged to older adults with multiple sclerosis.
A Risk Score for Predicting Multiple Sclerosis.
Exercise Training in Progressive Multiple Sclerosis: A Comparison of Recumbent Stepping and Body Weight-Supported Treadmill Training.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
Disability progression in aggressive multiple sclerosis.
Identification of Ser-Pro-Cys-Peptide in Blood Serum of Multiple Sclerosis Patients.
Acute disseminated encephalomyelitis in a case of autoimmune haemolytic anaemia: a rare association.
Assessment of vitamin D status - a changing landscape.
Aging-Resilient Associations between the Arcuate Fasciculus and Vocabulary Knowledge: Microstructure or Morphology?
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Regional differences in interhemispheric structural fibers in healthy, term infants.
Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report.
Autologous hematopoietic cell transplantation in multiple sclerosis.
Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure.
Effects of whole-body vibration training in patients with multiple sclerosis: A systematic review.
The choroid plexus in health and in disease: Dialogues into and out of the brain.
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia].
Effect of cognitive behavioral therapy on MS patients' quality of life. A multi-centre controlled trial.
Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
Pages
« first
‹ previous
…
815
816
817
818
819
820
821
822
823
…
next ›
last »